| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |